2019
DOI: 10.1007/s11673-019-09924-2
|View full text |Cite
|
Sign up to set email alerts
|

Co-payment for Unfunded Additional Care in Publicly Funded Healthcare Systems: Ethical Issues

Abstract: The burdens of resource constraints in publicly funded healthcare systems urge decision makers in countries like Sweden, Norway and the UK to find new financial solutions. One proposal that has been put forward is co-payment-a financial model where some treatment or care is made available to patients who are willing and able to pay the costs that exceed the available alternatives fully covered by public means. Co-payment of this sort has been associated with various ethical concerns. These range from worries t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…This may, potentially, be something that individual patients would benefit from knowing about, and hence in this sense the information about them can be actionable. Patients can, for instance, turn to private health care providers, whether those providers coexist within the publicly funded system or work through co-payment solutions [ 16 ]. Informing patients about such possibilities is mirrored in GMC guidelines, where it is clarified that other information that can be relevant includes “any treatments that you believe have greater potential benefit for the patient than those you or your organization can offer” [ 17 ].…”
Section: What Do Law and Policy Tell Us?mentioning
confidence: 99%
“…This may, potentially, be something that individual patients would benefit from knowing about, and hence in this sense the information about them can be actionable. Patients can, for instance, turn to private health care providers, whether those providers coexist within the publicly funded system or work through co-payment solutions [ 16 ]. Informing patients about such possibilities is mirrored in GMC guidelines, where it is clarified that other information that can be relevant includes “any treatments that you believe have greater potential benefit for the patient than those you or your organization can offer” [ 17 ].…”
Section: What Do Law and Policy Tell Us?mentioning
confidence: 99%
“…People typically feel good about being able to choose and, conversely, feel frustrated when they are being barred from a choice between alternatives that could have been offered to them. 14 The marketing of substitute insurance might emphasize a choice of better amenity or faster access to care, bypassing public-sector priority setting. 15 Private payment for improved amenity-a bigger room or better food-does not impinge fundamentally on equity.…”
Section: Private Health Insurancementioning
confidence: 99%
“…In these conditions, customers have genuine freedom of choice across a wide range of, as it were, selling points (many of which are not directly related to refractive correction). It is by no means obvious that this freedom is transferable to the public sector—at least, in the absence of a hybrid model where patients are allowed to part-fund products that are not available within the public sector [ 9 ]. Now, nothing rules out a parallel, private system like the one we have today.…”
Section: The Case Against Public Funding Of Refracmentioning
confidence: 99%
“…Spectacles were removed from the public health system at that point mainly for fiscal reasons. 9 This straightforward argument hardly convinces anyone-at least, not without linking it to an assessment of public need and the alternatives. If the mere fact that something is expensive were a satisfactory argument, we could shut down the publicly funded health care system altogether.…”
Section: Case 5: Gretchenmentioning
confidence: 99%